Group items tagged

Clinical Genomics Market By Test Type (Diagnostic, Genetic, Newborn Screening, Prenatal, Carrier Screening), Software, Method (Molecular, Chromosomal, Biochemical Tests), End User (Hospitals and Clinics) - Global Forecast to 2023

Surrogate The mother must be a woman who is able to take care of herself in her family and There must be no objection from her family members, she must be willing to Undergo thorough physical evaluation and Biochemical tests.

GSH has multiple functions in vivo. In the first place, GSH plays an important role in the biochemical defense system of human body and possesses many physiological functions. The main physiological function is that it can clear the free radicals in human body. And as a kind of important antioxidants in the body, it is used to protect mercapto in proteins and enzymes. Second, GSH can enhance human immunity and it has the functions of maintaining health and anti-aging. Third, GSH can protect hemoglobin (HGB) from oxidization of hydrogen peroxide and free radicals, which guarantees HGB to work normally and continually in oxygen transport. Fourth, GSH protects -SH group in enzymes, this can make for the full play of enzyme activities. GSH also can inhabit fatty liver caused by alcohol. Finally, for the hypoleucocytosis caused by radioactive rays and radiopharmaceutical, GSH provides a strong protection. It can combine with toxic compounds, heavy metal ions (HMI) or carcinogenic substance and contribute to eliminate from the body and have the effect of neutralization detoxification in the end.

A collection of fats in the liver cells is called fatty liver. This condition is often referred to as steatosis hepatis. Fatty liver, by itself though abnormal is a relative harmless condition. The liver incidentally is the largest organ in the human body. It has various roles in keeping the biochemical balance intact.

The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, growing at a CAGR of 11.7% from 2015 to 2020. A strong trend of increasing healthcare expenditure will majorly drive the growth of the market. Other growth factors include increasing R&D spending and growth in proteomics research. The increasing use of protein labeling in in vitro labeling, in vivo labeling, and bioorthogonal labeling methods will provide opportunities for market growth.